These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 35693423)
21. Seroprevalence of SARS-CoV-2 spike IgG antibodies after the second BNT162b2 mRNA vaccine in Japanese kidney transplant recipients. Hamaya T; Hatakeyama S; Yoneyama T; Tobisawa Y; Kodama H; Fujita T; Murakami R; Fujita N; Okamoto T; Yamamoto H; Yoneyama T; Hashimoto Y; Saitoh H; Narumi S; Tomita H; Ohyama C Sci Rep; 2022 Apr; 12(1):5876. PubMed ID: 35393481 [TBL] [Abstract][Full Text] [Related]
22. Humoral Immunogenicity to SARS-CoV-2 Vaccination in Liver Transplant Recipients: A Systematic Review and Meta-Analysis. Yoo JJ; Yon DK; Lee SW; Shin JI; Kim BK Int J Biol Sci; 2022; 18(15):5849-5857. PubMed ID: 36263175 [TBL] [Abstract][Full Text] [Related]
23. Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases. Thuluvath PJ; Robarts P; Chauhan M J Hepatol; 2021 Dec; 75(6):1434-1439. PubMed ID: 34454993 [TBL] [Abstract][Full Text] [Related]
24. Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2). Griessbach A; Chammartin F; Abela IA; Amico P; Stoeckle MP; Eichenberger AL; Hasse B; Braun DL; Schuurmans MM; Müller TF; Tamm M; Audigé A; Mueller NJ; Rauch A; Günthard HF; Koller MT; Trkola A; Epp S; Amstutz A; Schönenberger CM; Taji Heravi A; Papadimitriou-Olivgeris M; Casutt A; Manuel O; Kusejko K; Bucher HC; Briel M; Speich B; Open Forum Infect Dis; 2023 Nov; 10(11):ofad536. PubMed ID: 38023564 [TBL] [Abstract][Full Text] [Related]
25. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336 [TBL] [Abstract][Full Text] [Related]
26. Predictive Factors for Humoral Response After 2-dose SARS-CoV-2 Vaccine in Solid Organ Transplant Patients. Marion O; Del Bello A; Abravanel F; Faguer S; Esposito L; Laure Hebral A; Bellière J; Izopet J; Kamar N Transplant Direct; 2022 Jan; 8(1):e1248. PubMed ID: 34966837 [TBL] [Abstract][Full Text] [Related]
27. Analysis of the Specific Immune Response after the Third Dose of mRNA COVID-19 Vaccines in Organ Transplant Recipients: Possible Spike-S1 Reactive IgA Signature in Protection from SARS-CoV-2 Infection. Miele M; Busà R; Russelli G; Sorrentino MC; Di Bella M; Timoneri F; Vitale G; Calzolari E; Vitulo P; Mularoni A; Conaldi PG; Bulati M Microorganisms; 2022 Aug; 10(8):. PubMed ID: 36013981 [No Abstract] [Full Text] [Related]
28. Unexpectedly High Efficacy of SARS-CoV-2 BNT162b2 Vaccine in Liver versus Kidney Transplant Recipients-Is It Related to Immunosuppression Only? Nazaruk P; Monticolo M; Jędrzejczak AM; Krata N; Moszczuk B; Sańko-Resmer J; Pilecki T; Urbanowicz A; Florczak M; Pączek L; Foroncewicz B; Mucha K Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960200 [TBL] [Abstract][Full Text] [Related]
29. Determinants of Antibody Response to a Third SARS-CoV-2 mRNA Vaccine Dose in Solid Organ Transplant Recipients: Results from the Prospective Cohort Study COVAC-Tx. Balsby D; Nilsson AC; Möller S; Lindvig SO; Davidsen JR; Abazi R; Poulsen MK; Holden IK; Justesen US; Bistrup C; Johansen IS Vaccines (Basel); 2022 Apr; 10(4):. PubMed ID: 35455314 [TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 Vaccination in Kidney Transplant Recipients-Stratified Analysis of the Humoral Immune Response. Lammert A; Schnuelle P; Rabenau HF; Ciesek S; Krämer BK; Göttmann U; Drüschler F; Keller C; Rose D; Blume C; Thomas M; Kohmer N; Lammert A Transplant Direct; 2022 Nov; 8(11):e1384. PubMed ID: 36259077 [TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2 Vaccines: Safety and Immunogenicity in Solid Organ Transplant Recipients and Strategies for Improving Vaccine Responses. Grupper A; Katchman H Curr Transplant Rep; 2022; 9(1):35-47. PubMed ID: 35096509 [TBL] [Abstract][Full Text] [Related]
32. Humoral immunity against SARS-CoV-2 variants including omicron in solid organ transplant recipients after three doses of a COVID-19 mRNA vaccine. Saharia KK; Husson JS; Niederhaus SV; Iraguha T; Avila SV; Yoo YJ; Hardy NM; Fan X; Omili D; Crane A; Carrier A; Xie WY; Vander Mause E; Hankey K; Bauman S; Lesho P; Mannuel HD; Ahuja A; Mathew M; Avruch J; Baddley J; Goloubeva O; Shetty K; Dahiya S; Rapoport AP; Luetkens T; Atanackovic D Clin Transl Immunology; 2022; 11(5):e1391. PubMed ID: 35505864 [TBL] [Abstract][Full Text] [Related]
33. Patients After Orthotopic Heart Transplantation With COVID-19: Are We Fast Enough With Vaccinations? Kuczaj A; Przybyłowski P Transplant Proc; 2022 May; 54(4):897-900. PubMed ID: 35414424 [TBL] [Abstract][Full Text] [Related]
34. Early humoral immune response to two doses of severe acute respiratory syndrome coronavirus 2 vaccine in a diverse group of solid organ transplant candidates and recipients. Huang HJ; Yi SG; Mobley CM; Saharia A; Bhimaraj A; Moore LW; Kloc M; Adrogue HE; Graviss EA; Nguyen DT; Eagar TN; Jones SL; Ankoma-Sey V; MacGillivray TE; Knight RJ; Gaber AO; Ghobrial RM Clin Transplant; 2022 May; 36(5):e14600. PubMed ID: 35083796 [TBL] [Abstract][Full Text] [Related]
35. SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients. Hallett AM; Greenberg RS; Boyarsky BJ; Shah PD; Ou MT; Teles AT; Krach MR; López JI; Werbel WA; Avery RK; Bae S; Tobian AA; Massie AB; Higgins RSD; Garonzik-Wang JM; Segev DL; Bush EL J Heart Lung Transplant; 2021 Dec; 40(12):1579-1588. PubMed ID: 34456108 [TBL] [Abstract][Full Text] [Related]
36. Risk Factors Associated With an Impaired Antibody Response in Kidney Transplant Recipients Following 2 Doses of the SARS-CoV-2 mRNA Vaccine. Yi SG; Moore LW; Eagar T; Graviss EA; Nguyen DT; Ibrahim H; Huang HJ; Hobeika M; McMillan R; Saharia A; Mobley C; Podder H; Drews A; Ghobrial RM; Gaber AO; Knight RJ Transplant Direct; 2022 Jan; 8(1):e1257. PubMed ID: 34912946 [TBL] [Abstract][Full Text] [Related]
37. Humoral and Cellular Immune Responses of Solid Organ Transplant Patients on Belatacept to Three Doses of mRNA-Based Anti-SARS-CoV-2 Vaccine. Abravanel F; Marion O; Del Bello A; Beunon T; Romieu-Mourez R; Couat C; Pucelle M; Staes L; Guitard J; Esposito L; Faguer S; Kamar N; Izopet J Vaccines (Basel); 2022 Feb; 10(3):. PubMed ID: 35334985 [TBL] [Abstract][Full Text] [Related]
38. Serological Responses after a Fourth Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis. Mu Y; Wu H; Jiang Z; Liu K; Xue X; Zhang W; Chen Z Vaccines (Basel); 2023 Jun; 11(7):. PubMed ID: 37514946 [TBL] [Abstract][Full Text] [Related]
39. Immune Response to BNT162b2 in Solid Organ Transplant Recipients: Negative Impact of Mycophenolate and High Responsiveness of SARS-CoV-2 Recovered Subjects against Delta Variant. Cassaniti I; Bergami F; Arena F; Sammartino JC; Ferrari A; Zavaglio F; Curti I; Percivalle E; Meloni F; Pandolfi L; Pellegrini C; Turco A; Seminari E; Pattonieri EF; Gregorini M; Rampino T; Sarasini A; Lilleri D; Baldanti F Microorganisms; 2021 Dec; 9(12):. PubMed ID: 34946223 [TBL] [Abstract][Full Text] [Related]
40. Humoral and cellular immune response after severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccination in heart transplant recipients: An observational study in France. Casenaz A; Grosjean S; Aho-Glélé LS; Bour JB; Auvray C; Manoha C Front Med (Lausanne); 2022; 9():1027708. PubMed ID: 36388890 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]